List View

Displaying 2,826 - 2,850 of 2,995

AML and MDS: New Directions

Lymphoma: State of the Art

Novel Targets in Hematologic Malignancies

Hippo-Yap Pathway

Targeting RAS-RAF-MAPK Pathway

Targeting the Microbiome and Optimizing Immunotherapy in Cancer

Hormone Therapy in Breast Cancer: New Directions

New Biomarkers in Breast Cancer

HER2 Targeted Therapies: Recent Advances

ALL REVOLUTION: Improving Outcomes for ALL

Recent Advances in Breast Cancer

State of the Art in Genitourinary Cancers

New Therapeutic Directions in Lung Cancer

Therapeutic Advances in Gynecologic Oncology

Latest Advances in Gastrointestinal Cancers

Updates in Kidney and Bladder Cancers: Immunotherapy and Targeted Therapy

Gynecologic Malignancies: New Therapeutic Developments

Prostate Cancer: What is the Best Combination Therapy?

Immunotherapy in NSCLC: Advanced Disease and Resistance

Targeted Therapy in NSCLC

Small-Cell Lung Cancer

Updates in CML and CLL

B-cell and T-cell NHL Challenges

Post-Neoadjuvant Therapy after Residual Disease: How to Approach This Problem?

New Endocrine and Targeted Agents for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer